London Calling 2024 - Speakers
Speakers
Check out the line up of speaking at London Calling 2024.
A
)
Dr. Ahmad Abou TayounAl Jalila Children’s Specialty Hospital & Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, UAE
)
Adam DavidovichJohns Hopkins University, USA
Antoni P.A. HendrickxNational Institute for Public Health and the Environment, Netherlands
)
Andre HolzerHolzer Scientific Consultancy, Germany
)
Anoushka JoglekarNew York Genome Center, USA
)
Adrien LegerDirector, Modified Base Research, Oxford Nanopore Technologies
)
Alex ShawImperial College London, UK
)
Alex TrotterDevelopment Scientist – Translational Development, Oxford Nanopore Technologies
)
Amanda WarrThe Roslin Institute, UK
)
Alexander WittenbergKeyGene, Netherlands
)
Akelia Wauchope-OdumboAssociate Director, Technical Applications — Americas, Oxford Nanopore Technologies
B
)
Bryant CatanoSenior Product Support Scientist, Oxford Nanopore Technologies
)
Prof. Benjamin KippMayo Clinic, USA
)
Bosheng LiInstitute of Advanced Agricultural Sciences, Peking University, China
Ben PriceNatural History Museum, UK
C
)
Claire AndersonUniversity College London, UK
)
Chris AlderBioinformatician, Oxford Nanopore Technologies
)
Chao Chun LiuSimon Fraser University, Canada
Dr. Chuck CooperbioMérieux, France
)
Dr. Clemens JakobiLonza, Switzerland
)
Dr. Carolyn TregidgoVP, Late Stage and Applied Product Development, Oxford Nanopore Technologies
D
Dan FordhamDirector, Strategic Product Management EMEA, Oxford Nanopore Technologies
)
Dominic HalliwellUniversity of Bath, UK
)
Dr. Danny E. MillerUniversity of Washington, USA
)
Devin OglesbeeMayo Clinic, USA
E
)
Dr. Emma BapleUniversity of Exeter, UK
)
Ethan Hill‘Iolani School, USA
)
Emma WhiteVP, Marketing Operations, Oxford Nanopore Technologies
)
Eddy de BoerUniversity Medical Center Groningen, Netherlands
H
)
Dr. Helen Bulbeckbrainstrust, UK
)
Dr. Helen GunterBASE mRNA Facility, The University of Queensland, Australia
)
Hanlee JiStanford University, USA
Heather Ritchie-ParkerRoyal Zoological Society of Scotland, UK
I
)
Prof. Ian AbbsGuy’s and St Thomas’ NHS Foundation Trust, UK
)
Dr. Inès HassanTony Blair Institute for Global Change, UK
J
)
Jessica AndersonSenior Field Applications Scientist, Oxford Nanopore Technologies
)
Jean-Francois BrepsonPathoQuest, France
)
Prof. Sir John BellEllison Institute of Technology Oxford, UK
)
Jimmy CreithField Applications Scientist, Bioinformatics, Oxford Nanopore Technologies
)
Julie DragonUniversity of Vermont, USA
)
Jade ForsterUniversity of Southampton, UK
)
Dr. Janessa LaskinBC Cancer Centre & University of British Columbia, Canada
)
Joanne TrinhInstitute of Neurogenetics, Germany
)
Prof. Joris VermeeschKU Leuven, Belguim
K
)
Kimberley BillingsleyNational Institutes of Health, USA
Kara DicksProgramme Manager, Conservation Genomics—ORG.ONE, Oxford Nanopore Technologies
Dr. Karen SherwoodUniversity of British Columbia, Canada
)
Katharina WolffTU Braunschweig, Germany
L
)
Lauren LuiLawrence Berkeley National Laboratory, USA
)
Logan MulroneyEMBL-EBI & Center for Genomic Science at Italian Institute of Technology, Italy
)
Dr. Luke W. MeredithWorld Health Organization Eastern Mediterranean Region, Egypt
Dr. Luca MazzarellaEuropean Institute of Oncology, Italy
Prof. Laurent MesnardSorbonne University, France
)
Lorey SmithPeter MacCallum Cancer Centre, Australia
)
Lara UrbanHemholtz AI, Germany
)
Laura WhiteUniversity of Colorado School of Medicine, USA
M
)
Medini AnnavajhalaColumbia University Irving Medical Center, USA
)
Prof. Matt BrownGenomics England, UK
)
Morgan GueuningBlood Transfusion Service, Switzerland
)
Morghan LucasMedical Genetics Center, Germany
Michael NakaiPeter MacCallum Cancer Centre, Australia
Dr. Matt ParkerDirector, Clinical Bioinformatics Software, Oxford Nanopore Technologies
)
Max SchmidtGeisenheim University, Germany
)
Mile SikicGenome Institute of Singapore, A*STAR, Singapore
)
Mrinalini WatsaSan Diego Zoo Wildlife Alliance, USA
N
)
Natalia GarciaBioinformatics Workflow Developer, Oxford Nanopore Technologies
)
Ndack NdiayePasteur Institute, Senegal
)
Nick SeddonOptum Genomics, USA
P
)
Paul ArvidsonGenomics England & SWAN, UK
)
Ping LuPeking University, China
)
Prof. Dr. Pieter WesselingPrincess Máxima Center for Pediatric Oncology & Amsterdam University Medical Centers, Netherlands
R
Dr. Rahul BatraGuy's & St Thomas' Hospital NHS Trust, UK
)
Rui ChenBaylor College of Medicine, USA
)
Rea KobialkaInstitute of Animal Hygiene and Veterinary Public Health, Germany
)
Rachel RubinsteinManager, Software Technical Product Management, Oxford Nanopore Technologies
)
Rosemary Sinclair DokosSVP, Product and Programme Management, Oxford Nanopore Technologies
)
Rhys WhiteInstitute of Environmental Science and Research, New Zealand
S
)
Sergey BatalovRady Children’s Institute for Genomic Medicine, USA
)
Seanne P. BuckwalterMayo Clinic, USA
Sam DavisPrincipal Scientist, Machine Learning, Oxford Nanopore Technologies
)
Sneha GoenkaStanford University & Princeton University, USA
)
Sarah GriffithsBioinformatics Workflow Developer, Oxford Nanopore Technologies
)
Sirisha HeskethClinical Bioinformatician, Oxford Nanopore Technologies
Sofia KudashevaEarlham Institute, UK
)
Susie LeeTechnical Product Manager, Basecalling and Models, Oxford Nanopore Technologies
)
Sean McKenzieAssociate Director, Genomic Applications Bioinformatics, Oxford Nanopore Technologies
)
Dr. Simon PaineNottingham University Hospitals NHS Trust, UK
Steph WilbrahamDirector, Automation Product Management, Oxford Nanopore Technologies
T
)
Thias Oberg BoesenNovo Nordisk A/S, Denmark
)
Tomás Di DomenicoNational Cancer Research Center, Spain
)
Tomasz DobrzyckiField Applications Scientist, New Product Introduction, Oxford Nanopore Technologies
)
Dr. Telmo GraçaLonza, Switzerland
)
Dr. Thomas R. KreilTakeda, Austria
)
Temitayo A. OlagunjuUniversity of Idaho, USA
)
Tetyana VasylyevaUniversity of California, Irvine, USA
)
Tjakko van HamErasmus University Medical Center, Netherlands
)
)
)
Oxford Nanopore Technologies
Cate Paschal
)
- Job title
- Institution
- Seattle Children's Hospital, USA
- Biography
Cate Paschal received her PhD from Weill Cornell Medical College, New York. She is board certified in clinical cytogenetics and genomics, as well as clinical molecular genetics and genomics. Cate is the director of the integrated cytogenetics and molecular genetics laboratory at Seattle Children’s Hospital, where she signs out a variety of clinical tests for both pediatric oncology and constitutional disorders. She is also Clinical Assistant Professor in the department of Laboratory Medicine and Pathology at the University of Washington.